Global Vagus Nerve Stimulator Market

Vagus nerve stimulators are designed to avoid seizers by sending consistent, mild pulses of electrical signals to brain through vagus nerve. These pulses are delivered by using devices which resembles pacemaker. Vagus nerve is an important part of automatic nervous systems which controls involuntary functions of body like heart rate. Vagus nerve stimulators are called as pacemaker of the brain.

Market Drivers

Rise in prevalence of neurological disorders is the key driving factor which is expected to drive the global vagus nerve stimulator market growth. Furthermore, increase in investment of biotechnology and pharmaceutical industries in research and development activities will have the positive impact on market growth. Moreover, increase in technological advancements will propel the market growth during this forecast period. For instance, in July 2017, ElectroCore LLC had launched its new non-invasive vagus nerve stimulator which named as gamma Core.  This device is useful in treatment of pain associated with episodic cluster headache in adult patients.

 

Market Restraints

However, lack of skilled professionals is the major challenging factor which is expected to obstruct the global vagus nerve stimulator market growth. Also, high cost associated with neurostimulator devices which are expected to hinder the market growth.

 

Market Segmentation

Global Vagus Nerve Stimulator Market is segmented into product type such as Implantable VNS Devices, and External VNS Devices, by biomaterial such as Ceramics, Metallic, and Polymerics, by application such as Depression, Epilepsy, and Migraine. Further, market is segmented into end user such as Hospitals, Ambulatory Surgical Centers, and Others.

Also, Global Vagus Nerve Stimulator Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

 

Market Key Players

Various key players are discussed in this report such as Medtronic Plc, Nevro Corporation, EnteroMedics Inc, Bioness Inc, BioControl Medical, Aleva Neurotherapeutics SA, Boston Scientific Corporation, LivaNova Plc, ElectroCore LLC, and NeuroPace Inc.

 

Market Taxonomy

By Product Type

  • Implantable VNS Devices
  • External VNS Devices

 

By Biomaterial

  • Ceramics
  • Metallic
  • Polymerics

 

By Application

  • Depression
  • Epilepsy
  • Migraine

 

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

 

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

 

Key Questions Addressed by the Report

  • What are the Key Opportunities in Global Vagus Nerve Stimulator Market?
  • What will be the growth rate from 2019 to 2027?
  • Which segment/region will have highest growth?
  • What are the factors that will impact/drive the Market?
  • What is the competitive Landscape in the Industry?
  • What is the role of key players in the value chain?
  • What are the strategies adopted by key players?

                   

Global Vagus Nerve Stimulator Market

1 Introduction          

1.1 Objective of the Study

1.2 Market definition

1.3 Market Scope

 

2 Research Methodology

2.1 Data Mining

2.2 Validation

2.3 Primary Interviews

2.4 List of Data Sources

 

3 Executive Summary

4 Global Vagus Nerve Stimulator Market Outlook

4.1 Overview

4.2 Market Dynamics

4.2.1 Drivers

4.2.2 Restraints

4.2.3 Opportunities

4.3 Porters Five Force Model

4.4 Value Chain Analysis

 

5 Global Vagus Nerve Stimulator Market, By Product Type

5.1 Y-o-Y Growth Comparison, By Product Type

5.2 Global Vagus Nerve Stimulator Market Share Analysis, By Product Type

5.3 Global Vagus Nerve Stimulator Market Size and Forecast, By Product Type

5.3.1 Implantable VNS Devices

5.3.2 External VNS Devices

 

6 Global Vagus Nerve Stimulator Market, By Biomaterial

6.1 Y-o-Y Growth Comparison, By Biomaterial

6.2 Global Vagus Nerve Stimulator Market Share Analysis, By Biomaterial

6.3 Global Vagus Nerve Stimulator Market Size and Forecast, By Biomaterial

6.3.1 Ceramics

6.3.2 Reusable

6.3.3Polymerics

 

7 Global Vagus Nerve Stimulator Market, By Application

7.1 Y-o-Y Growth Comparison, By Application

7.2 Global Vagus Nerve Stimulator Market Share Analysis, By Application

7.3 Global Vagus Nerve Stimulator Market Size and Forecast, By Application

7.3.1 Depression

7.3.2 Epilepsy

7.3.3 Margarine

 

8 Global Vagus Nerve Stimulator Market, By End User

8.1 Y-o-Y Growth Comparison, By End User

8.2 Global Vagus Nerve Stimulator Market Share Analysis, By End User

8.3 Global Vagus Nerve Stimulator Market Size and Forecast, By End User

8.3.1 Hospitals

8.3.2 Ambulatory Surgical Center

8.3.3 Others

 

9Global Vagus Nerve Stimulator Market, By Region

9.1 Global Vagus Nerve Stimulator Market Share Analysis, By Region

9.2 Global Vagus Nerve Stimulator Market Share Analysis, By Region

9.3 Global Vagus Nerve Stimulator Market Size and Forecast, By Region

 

10 North America Vagus Nerve Stimulator Analysis and Forecast (2017 – 2027)

10.1 Introduction

10.2 North America Vagus Nerve Stimulator Market Share Analysis, By Product Type

10.3 North America Vagus Nerve Stimulator Market Size and Forecast, By Biomaterial

10.4 North America Vagus Nerve Stimulator Market Size and Forecast, By Application

10.5 North America Vagus Nerve Stimulator Market Size and Forecast, By End User

10.6 North America Vagus Nerve Stimulator Market Size and Forecast, By Country

10.6.1 U.S.

10.6.2 Canada

10.6.3 Mexico

 

11Europe Vagus Nerve Stimulator Market Analysis and Forecast (2017 – 2027)

11.1 Introduction

11.2 Europe Vagus Nerve Stimulator Market Share Analysis, By Product Type

11.3 Europe Vagus Nerve Stimulator Market Size and Forecast, By Biomaterial

11.4 Europe Vagus Nerve Stimulator Market Size and Forecast, By Application

11.5 Europe Vagus Nerve Stimulator Market Size and Forecast, By End User

11.6 Europe Vagus Nerve Stimulator Market Size and Forecast, By Country

11.6.1 Germany

11.6.2 France

11.6.3 UK

11.64. Rest of Europe

 

12Asia Pacific Vagus Nerve Stimulator Market Analysis and Forecast (2017 – 2027)

12.1 Introduction

12.2 Asia Pacific Vagus Nerve Stimulator Market Share Analysis, By Product Type

12.3 Asia Pacific Vagus Nerve Stimulator Market Size and Forecast, By Biomaterial 

12.4 Asia Pacific Vagus Nerve Stimulator Market Size and Forecast, By Application

12.5 Asia Pacific Vagus Nerve Stimulator Market Size and Forecast, By End User

12.6 Asia Pacific Vagus Nerve Stimulator Market Size and Forecast, By Country

12.6.1 China

12.6.2 Japan

12.6.3 India

12.6.4. Rest of Asia Pacific

 

13Latin America Vagus Nerve Stimulator Market Analysis and Forecast (2017 – 2027)

13.1 Introduction

13.2 Latin America Vagus Nerve Stimulator Market Share Analysis, By Product Type

13.3 Latin America Vagus Nerve Stimulator Market Size and Forecast, By Biomaterial

13.4 Latin America Vagus Nerve Stimulator Market Size and Forecast, By Application

13.5 Latin America Vagus Nerve Stimulator Market Size and Forecast, By End User

13.6 Latin America Vagus Nerve Stimulator Market Size and Forecast, By Country

 

14Middle East Vagus Nerve Stimulator Market Analysis and Forecast (2017 – 2027)

14.1 Introduction

14.2 Middle East Vagus Nerve Stimulator Market Share Analysis, By Product Type

14.3 Middle East Vagus Nerve Stimulator Market Size and Forecast, By Biomaterial

14.4 Middle East Vagus Nerve Stimulator Market Size and Forecast, By Application

14.5 Middle East Vagus Nerve Stimulator Market Size and Forecast, By End User

14.6 Middle East Vagus Nerve Stimulator Market Size and Forecast, By Country

 

15Competitive Analysis

15.1 Competition Dashboard

15.2 Market share Analysis of Top Vendors

15.3 Key Development Strategies

 

16Company Profiles

16.1 Medtronic Plc

16.1.1 Overview

16.1.2 Offerings

16.1.3 Key Financials

16.1.4 Business Segment & Geographic Overview

16.1.5 Key Market Developments

16.1.6 Key Strategies

 

16.2 Nevro Corporation

16.2.1 Overview

16.2.2 Offerings

16.2.3 Key Financials

16.2.4 Business Segment & Geographic Overview

16.2.5 Key Market Developments

16.2.6 Key Strategies

 

16.3 EnteroMedics Inc

16.3.1 Overview

16.3.2 Offerings

16.3.3 Key Financials

16.3.4 Business Segment & Geographic Overview

16.3.5 Key Market Developments

16.3.6 Key Strategies

 

16.4 Bioness Inc

16.4.1 Overview

16.4.2 Offerings

16.4.3 Key Financials

16.4.4 Business Segment & Geographic Overview

16.4.5 Key Market Developments

16.4.6 Key Strategies

 

16.5 BioControl Medical

16.5.1 Overview

16.5.2 Offerings

16.5.3 Key Financials

16.5.4 Business Segment & Geographic Overview

16.5.5 Key Market Developments

16.5.6 Key Strategies

 

16.6 Aleva Neurotherapeutics SA

16.6.1 Overview

16.6.2 Offerings

16.6.3 Key Financials

16.6.4 Business Segment & Geographic Overview

16.6.5 Key Market Developments

16.6.6 Key Strategies

 

16.7 Boston Scientific Corporation

16.7.1 Overview

16.7.2 Offerings

16.7.3 Key Financials

16.7.4 Business Segment & Geographic Overview

16.7.5 Key Market Developments

16.7.6 Key Strategies     

 

16.8 LivaNova Plc

16.8.1 Overview

16.8.2 Offerings

16.8.3 Key Financials

16.8.4 Business Segment & Geographic Overview

16.8.5 Key Market Developments

16.8.6 Key Strategies 

 

16.9 ElectroCore LLC

16.9.1 Overview

16.9.2 Offerings

16.9.3 Key Financials

16.9.4 Business Segment & Geographic Overview

16.9.5 Key Market Developments

16.9.6 Key Strategies 

 

16.10 NeuroPace Inc

16.10.1 Overview

16.10.2 Offerings

16.10.3 Key Financials

16.10.4 Business Segment & Geographic Overview

16.10.5 Key Market Developments

16.10.6 Key Strategies